Clinical Scorecard: Breaking the Biomarker Bottlenecks: Part 2

At a Glance

Key Highlights

• AI ensures reproducibility in diagnostic results across different labs
• AI provides accurate quantitative results critical for therapy decisions
• AI captures complex cellular interactions beyond human interpretation
• Multimodal biomarkers powered by AI enhance patient selection strategies
• AI aids in monitoring therapy response for tailored treatment adjustments

Guideline-Based Recommendations

Diagnosis

• Utilize AI-enabled assays for consistent biomarker interpretation
• Incorporate proteomics and cellular structure analysis in diagnostics

Management

• Employ AI for therapy selection based on comprehensive biomarker data
• Adjust treatment regimens based on AI analysis of therapy response

Monitoring & Follow-up

• Use AI to consistently evaluate cellular structures during follow-ups
• Implement AI-driven insights to refine treatment decisions

Risks

• Inconsistent interpretations by pathologists can lead to misdiagnosis
• Lack of regulatory clarity may hinder the adoption of AI diagnostics

Patient & Prescribing Data

Patients with various tumor types requiring personalized treatment

AI can identify optimal therapy regimens based on detailed biomarker analysis

Clinical Best Practices

• Foster partnerships with technology and data analytics companies
• Advocate for regulatory clarity regarding AI diagnostics
• Adapt business models to accommodate novel AI-driven technologies

References

• Breaking the Biomarker Bottlenecks: Part 2